According to the current analysis of Reports and Data, the global drug eluting stent market was valued at USD 5.63 Billion in 2018 and is expected to reach USD 8.74 Billion by year 2026, at a CAGR of 5.67 %. The study covers in-depth analysis of drug eluting stents and its extensive use in the cardiovascular diseases. Drug eluting stents are metal stents that are coated with a pharmacologic agent (drug) that is known to suppress restenosis (the reblocking or closing up of an artery after angioplasty due to excess growth inside or at the edge of the stent). Drug eluting stents are usually preferred over bare metal stents for most people. Drug eluting stents are generally to keep the blockage from recurring compared to bare metal stents. One of the major objectives of drug eluting stents is to limit neointimal hyperplasia. The global drug eluting stent market is propelled by number of factors such as rise in the geriatric population, increasing prevalence of cardiovascular diseases, growing acceptance for minimally invasive endovascular surgeries. However, strict regulatory approval process and lack of skilled professionals are major hindrance for the growth of global drug eluting market during 2019-2026. Conversely, the emerging markets of Asia-Pacific and Latin America are anticipated to provide lucrative growth opportunities to the market players involved in the global drug eluting stent market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1786
The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.
Key companies operating in the market include:
Terumo Corporation, Biosensors, Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1786
The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Drug Eluting Stent market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
On basis of product types and application offered by the Drug Eluting Stent industry, the market is segmented into:
Drug Eluting Stent Market, by Coating (Revenue, USD Million; 2016–2026)
- Polymer based coating
- Biodegradable
- Non-biodegradable
- Polymer free coating
- Microporous Surface
- Microstructured Surface
- Slotted Tubular Surface
- Nanoporous Surface
Drug Eluting Stent Market, by Application (Revenue, USD Million; 2016–2026)
- Coronary Artery Disease
- Peripheral Artery Disease
Drug Eluting Stent Market, by End Use (Revenue, USD Million; 2016–2026)
- Hospitals
- Cardiology Centers
- Ambulatory Surgical Centers
The regional analysis covers:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/drug-eluting-stent-market
Benefits of Drug Eluting Stent Market Report:
- Panoramic overview of the opportunities and risks in the Drug Eluting Stent sector
- Study of recent innovations and developments in the industry
- Comprehensive study of the growth pattern of the Drug Eluting Stent industry
- In-depth assessment of the competitive landscape of the key players of the Drug Eluting Stent industry
- Analysis of the Drug Eluting Stent market drivers, constraints, and opportunities
- Assessment of technological developments and latest trends of the industry
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1786
Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.
Browse More Reports :
Personal Mobility Devices Market @ https://www.medgadget.com/2020/03/personal-mobility-devices-market-to-reach-usd-13-25-billion-by-2027-topro-carex-health-brand-incorporation-invacare.html
Pharmacogenomics (PGx) Market @ https://www.medgadget.com/2020/03/pharmacogenomics-pgx-market-to-reach-usd-11-96-billion-by-2027-abbott-laboratories-admera-health-llc-agena-biosciences-inc-cancer-genetics.html
Hemodialysis and Peritoneal Dialysis Market @ https://www.medgadget.com/2020/03/hemodialysis-and-peritoneal-dialysis-market-to-reach-usd-119-15-billion-by-2027-medical-care-ag-co-davita-healthcare-partners-baxter-international-b-braun-melsungen-ag.html
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
